Advertisement

Topics

EU Firsts For CAR-T & PRIME As EMA Grants Kite Accelerated Assessment

08:29 EDT 1 Aug 2017 | Elsevier Business Intelligence

Kite Pharma claims it has filed the first EU application to market a CAR T-cell therapy, and says that its...  ...

Original Article: EU Firsts For CAR-T & PRIME As EMA Grants Kite Accelerated Assessment

NEXT ARTICLE

More From BioPortfolio on "EU Firsts For CAR-T & PRIME As EMA Grants Kite Accelerated Assessment"

Quick Search
Advertisement